Trial intelligence / Profile preview

T-cell Analysis for TNF-blocker Withdrawal in RA

NCT03736044Completed

Sponsor
Azienda Ospedaliero-Universitaria di Ferrara
Start
Nov 2013
Primary completion
Mar 2017
01

Overview

Open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Primary endpoint: Proportion of subjects who flare-up after cessation of anti-TNF therapy at 24 months. Started Nov 2013; status: completed.

02

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT03736044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03736044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call